Global Conference 2026

Part 2: What Will Success Against Cancer Look Like in 2035?

-

Progress in cancer research is increasingly likely to be defined not by isolated breakthroughs but by the ability to perceive risk earlier, act sooner, and learn continuously. This session will spotlight the scientific advances that are redefining how cancer is managed and shortening the distance between discovery and impact on the patient. Panelists will explore how these innovations could reshape what progress against cancer will look like by 2035. 

Stay informed by the Milken Institute

    Speakers

    Image

    Kent Bradley

    Chief Medical Executive, 10X Health
    Image

    James "Jay" Bradner

    Executive Vice President, Research and Development, Amgen
    Image

    Stephanie Kauffman

    President and Chief Operating Officer, Melanoma Research Alliance
    Image

    Bjorn Zoega

    CEO, King Faisal Hospital and Research Center